Kolexia
Pasquier David Oncologie radiothérapie
Pasquier David
Oncologie radiothérapie
Centre Oscar-Lambret
Lille, France
317 Activités
1.2 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs du sein Métastase tumorale Récidive tumorale locale Carcinomes Tumeurs du poumon Lésions radiques Carcinome pulmonaire non à petites cellules Métastase lymphatique

Collaborateurs

Voir plus
Lartigau Eric
Lartigau Eric
Centre Oscar-Lambret, Lille, France
Sargos Paul
Sargos Paul
Institut Bergonié, Bordeaux, France
Supiot Stephane
Supiot Stephane
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Latorzeff Igor
Latorzeff Igor
Hôpital Rangueil, Toulouse, France

Industries

Voir plus
Bayer
9 collaboration(s)
Dernière en 2023
Ipsen
7 collaboration(s)
Dernière en 2023
ELEKTA SAS
5 collaboration(s)
Dernière en 2020
Janssen
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
REPAIR: Relapse in Previously Irradiated Prostate Bed : a Phase I/II Study of Stereotactic Ablative Reirradiation Potentiated by Metformin
Essai Clinique (Institut Cancerologie de l'Ouest)   11 mars 2024
Response to "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients - A closer inspection will improve your vision".
Clinical and translational radiation oncology   21 février 2024
OligoRARE: Stereotactic Body Radiotherapy in Addition to Standard of Care Treatment in Patients With Rare Oligometastatic Cancers (OligoRARE): a Randomized, Phase 3, Open-label Trial
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   15 février 2024
BLAD-RAD01: Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy: a Prospective Randomized Comparative Phase II Trial
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   01 février 2024
STEREO-OS: Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
Essai Clinique (Unicancer)   11 décembre 2023
ROMANCE: Prospective Study of Omission of Whole-breast Radiotherapy Following Breast-conserving Surgery in Patients With Very Low Risk Ductal Carcinoma in Situ of the Breast
Essai Clinique (Unicancer)   11 décembre 2023
Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis.
Clinical and translational radiation oncology   08 décembre 2023
Reply to Nikolaos Grivas, Christos Zampaftis, Dimitris Ermidis, Ioannis Leotsakos, Ioannis Katafigiotis, and Markos Karavitakis's Letter to the Editor re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol 2023;6:399-405.
European urology oncology   01 décembre 2023
Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   23 novembre 2023
Bladder-ART: Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study
Essai Clinique (Unicancer)   09 novembre 2023